Результаты поиска - Karl Kieburtz

Отмена результатов
  1. 1
    A Randomized, Placebo-Controlled Trial of Latrepirdine in Huntington Disease

    A Randomized, Placebo-Controlled Trial of Latrepirdine in Huntington Disease по Karl Kieburtz

    Опубликовано 2010
    Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  2. 2
    The relationship between uric acid levels and Huntington's disease progression

    The relationship between uric acid levels and Huntington's disease progression по Peggy Auinger, Karl Kieburtz, Michael McDermott

    Опубликовано 2010
    Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  3. 3
    A review of disease progression models of Parkinson's disease and applications in clinical trials

    A review of disease progression models of Parkinson's disease and applications in clinical trials по Charles S. Venuto, Nicholas B. Potter, E. Ray Dorsey, Karl Kieburtz

    Опубликовано 2016
    Полный текст
    Revisão
    Добавить в Избранное
    Сохранить в:
  4. 4
    The relationship between CAG repeat length and clinical progression in Huntington's disease

    The relationship between CAG repeat length and clinical progression in Huntington's disease по Bernard Ravina, Megan Romer, Radu Constantinescu, Kevin Biglan, Alicia Brocht, Karl Kieburtz, Ira Shoulson, Michael McDermott

    Опубликовано 2008
    Полный текст Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  5. 5
    Levodopa and the Progression of Parkinson's Disease

    Levodopa and the Progression of Parkinson's Disease по Stanley Fahn, David Oakes, Ira Shoulson, Karl Kieburtz, Alice Rudolph, Anthony E. Lang, C. Warren Olanow, Caroline M. Tanner, Kenneth Marek

    Опубликовано 2004
    Полный текст Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  6. 6
    Moving Parkinson care to the home

    Moving Parkinson care to the home по E. Ray Dorsey, Floris P. Vlaanderen, Lucien JLPG Engelen, Karl Kieburtz, William Zhu, Kevin Biglan, Marjan J. Faber, Bastiaan R. Bloem

    Опубликовано 2016
    Полный текст
    Revisão
    Добавить в Избранное
    Сохранить в:
  7. 7
    Prevalence of dementia in rural China: impact of age, gender and education

    Prevalence of dementia in rural China: impact of age, gender and education по Dao Zhou, Ching‐Fen Wu, Haitao Qi, Jin‐Hu Fan, X. D. Sun, Peter G. Como, You‐Lin Qiao, Lu Zhang, Karl Kieburtz

    Опубликовано 2006
    Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  8. 8
    Trinucleotide repeat length and progression of illness in Huntington's disease.

    Trinucleotide repeat length and progression of illness in Huntington's disease. по Karl Kieburtz, Marcy E. MacDonald, Chiu-Yang Shih, Andrew Feigin, Kim Steinberg, Kathy Bordwell, Carol Zimmerman, Jayalakshmi Srinidhi, Jenny Sotack, James F. Gusella

    Опубликовано 1994
    Полный текст Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  9. 9
    Baseline prevalence and longitudinal evolution of non-motor symptoms in early Parkinson’s disease: the PPMI cohort

    Baseline prevalence and longitudinal evolution of non-motor symptoms in early Parkinson’s disease: the PPMI cohort по Tanya Simuni, Chelsea Caspell‐Garcia, Christopher S. Coffey, Daniel Weintraub, Brit Mollenhauer, Shirley Lasch, Caroline M. Tanner, Danna Jennings, Karl Kieburtz, Lana M. Chahine, Kenneth Marek

    Опубликовано 2017
    Полный текст Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  10. 10
    The Idiopathic Intracranial Hypertension Treatment Trial

    The Idiopathic Intracranial Hypertension Treatment Trial по Deborah I. Friedman, Michael McDermott, Karl Kieburtz, Mark J. Kupersmith, Ann Stoutenburg, John L. Keltner, Steven E. Feldon, Eleanor Schron, James J. Corbett, Michael Wall

    Опубликовано 2014
    Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  11. 11
    The Idiopathic Intracranial Hypertension Treatment Trial

    The Idiopathic Intracranial Hypertension Treatment Trial по Michael Wall, Mark J. Kupersmith, Karl Kieburtz, James J. Corbett, Steven E. Feldon, Deborah I. Friedman, David M. Katz, John L. Keltner, Eleanor Schron, Michael McDermott

    Опубликовано 2014
    Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  12. 12
    Effect of Acetazolamide on Visual Function in Patients With Idiopathic Intracranial Hypertension and Mild Visual Loss

    Effect of Acetazolamide on Visual Function in Patients With Idiopathic Intracranial Hypertension and Mild Visual Loss по Michael Wall, Michael McDermott, Karl Kieburtz, James J. Corbett, Steven E. Feldon, Deborah I. Friedman, David M. Katz, John L. Keltner, Eleanor Schron, Mark J. Kupersmith

    Опубликовано 2014
    Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  13. 13
    Results of the citalopram to enhance cognition in Huntington disease trial

    Results of the citalopram to enhance cognition in Huntington disease trial по Leigh J. Beglinger, William Adams, Douglas R. Langbehn, Jess G. Fiedorowicz, Ricardo E. Jorge, Kevin Biglan, John N. Caviness, Blair Olson, Robert G. Robinson, Karl Kieburtz, Jane S. Paulsen

    Опубликовано 2013
    Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  14. 14
    Phase 3 Trials of Solanezumab for Mild-to-Moderate Alzheimer's Disease

    Phase 3 Trials of Solanezumab for Mild-to-Moderate Alzheimer's Disease по Rachelle S. Doody, Ronald G. Thomas, Martin R. Farlow, Takeshi Iwatsubo, Bruno Vellas, Steven Joffe, Karl Kieburtz, Rema Raman, Xiaoying Sun, Paul Aisen, Eric Siemers, Hong Liu‐Seifert, Richard C. Mohs

    Опубликовано 2014
    Полный текст Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  15. 15
    A Phase 3 Trial of Semagacestat for Treatment of Alzheimer's Disease

    A Phase 3 Trial of Semagacestat for Treatment of Alzheimer's Disease по Rachelle S. Doody, Rema Raman, Martin R. Farlow, Takeshi Iwatsubo, Bruno Vellas, Steven Joffe, Karl Kieburtz, Feng He, Xiaoying Sun, Ronald G. Thomas, Paul Aisen, Eric Siemers, Gopalan Sethuraman, Richard C. Mohs

    Опубликовано 2013
    Полный текст Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  16. 16
    A randomized trial of inhaled levodopa (CVT-301) for motor fluctuations in Parkinson's disease

    A randomized trial of inhaled levodopa (CVT-301) for motor fluctuations in Parkinson's disease по Peter A. LeWitt, Robert A. Hauser, Donald G. Grosset, Fabrizio Stocchi, Marie Saint‐Hilaire, Aaron Ellenbogen, Mika Leinonen, Neil B. Hampson, Tia DeFeo-Fraulini, Martin I. Freed, Karl Kieburtz

    Опубликовано 2016
    Полный текст Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  17. 17
    Trichloroethylene: An Invisible Cause of Parkinson’s Disease?

    Trichloroethylene: An Invisible Cause of Parkinson’s Disease? по E. Ray Dorsey, Maryam Zafar, Samantha E. Lettenberger, Meghan Pawlik, Dan Kinel, Myrthe Frissen, Ruth B. Schneider, Karl Kieburtz, Caroline M. Tanner, Briana R. De Miranda, Samuel M. Goldman, Bastiaan R. Bloem

    Опубликовано 2023
    Полный текст Полный текст
    Revisão
    Добавить в Избранное
    Сохранить в:
  18. 18
    HIV-associated cognitive impairment before and after the advent of combination therapy

    HIV-associated cognitive impairment before and after the advent of combination therapy по Ned Sacktor, Michael McDermott, Karen Marder, Giovanni Schifitto, Ola A. Selnes, Justin C. McArthur, Yaakov Stern, Steven M. Albert, Donna Palumbo, Karl Kieburtz, Joy Antonelle de Marcaida, Bruce A. Cohen, Leon G. Epstein

    Опубликовано 2002
    Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  19. 19
    Continuous intrajejunal infusion of levodopa-carbidopa intestinal gel for patients with advanced Parkinson's disease: a randomised, controlled, double-blind, double-dummy study

    Continuous intrajejunal infusion of levodopa-carbidopa intestinal gel for patients with advanced Parkinson's disease: a randomised, controlled, double-blind, double-dummy study по C. Warren Olanow, Karl Kieburtz, Per Odin, Alberto J. Espay, David G. Standaert, Hubert H. Fernandez, Arvydas Vanagunas, Ahmed A. Othman, Katherine L. Widnell, Weining Robieson, Yili Pritchett, Krai Chatamra, Janet Benesh, Robert Lenz, Angelo Antonini

    Опубликовано 2013
    Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  20. 20
    Evaluation of HIV RNA and markers of immune activation as predictors of HIV-associated dementia

    Evaluation of HIV RNA and markers of immune activation as predictors of HIV-associated dementia по Jeffrey Sevigny, Steven M. Albert, Michael McDermott, Justin C. McArthur, Ned Sacktor, Kathy Conant, Giovanni Schifitto, Ola A. Selnes, Yaakov Stern, Daniel McClernon, Donna Palumbo, Karl Kieburtz, Garrett Riggs, Bevin Cohen, Leon G. Epstein, Karen Marder

    Опубликовано 2004
    Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:

Инструменты поиска: